Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response
暂无分享,去创建一个
A. Moser | F. Eichler | J. Hofmann | Z. Pálfi | S. Kemp | S. Hametner | J. Bauer | J. Berger | G. Regelsberger | M. Kunze | I. Weinhofer | S. Forss-Petter | J. Kühl | A. Buda | M. Traunfellner | S. Hesse | Andrea Villoria-Gonzalez | Andrea Villoria-González
[1] S. Elledge,et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.
[2] J. Ziegelbauer,et al. 25-Hydroxycholesterol Inhibits Kaposi’s Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses , 2021, mBio.
[3] F. Eichler,et al. Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy , 2021, Nature Communications.
[4] J. Frederiksen,et al. Epstein-Barr Virus and Multiple Sclerosis , 2020, Frontiers in Immunology.
[5] P. Lehner,et al. Dissecting Herpes Simplex Virus 1-Induced Host Shutoff at the RNA Level , 2020, Journal of Virology.
[6] Lauren S. Ryder,et al. Discovery of broad-spectrum fungicides that block septin-dependent infection processes of pathogenic fungi , 2020, Nature Microbiology.
[7] C. Svendsen,et al. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection , 2020, Cell Reports Medicine.
[8] D. Fremont,et al. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion , 2020, Proceedings of the National Academy of Sciences.
[9] Huamin Tang,et al. Human herpesvirus 6A promotes glycolysis in infected T cells by activation of mTOR signaling , 2020, PLoS pathogens.
[10] F. Paul,et al. Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[11] M. Shi,et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients , 2020, Emerging microbes & infections.
[12] A. Moser,et al. X‐linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies , 2019, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience.
[13] Nguyen Phuoc Long,et al. Comprehensive Multi-Omics Analysis Reveals Aberrant Metabolism of Epstein–Barr-Virus-Associated Gastric Carcinoma , 2019, Cells.
[14] Z. Fu,et al. Cholesterol 25-hydroxylase suppresses rabies virus infection by inhibiting viral entry , 2019, Archives of Virology.
[15] V. Mootha,et al. Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation , 2019, Cell metabolism.
[16] A. Scialdone,et al. Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection , 2018, Proceedings of the National Academy of Sciences.
[17] Jiho Jang,et al. Exogenous Addition of 25‐Hydroxycholesterol Reduces Level of Very Long‐Chain Fatty Acids in X‐Linked Adrenoleukodystrophy , 2019, ChemistryOpen.
[18] V. Tarakanova,et al. Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism , 2019, Viruses.
[19] Niyati T Desai,et al. A tumor-specific endogenous repetitive element is induced by herpesviruses , 2019, Nature Communications.
[20] D. Seelow,et al. De novo mutation in ELOVL1 causes ichthyosis, acanthosis nigricans, hypomyelination, spastic paraplegia, high frequency deafness and optic atrophy , 2018, Journal of Medical Genetics.
[21] O. Vitek,et al. Infection-Induced Peroxisome Biogenesis Is a Metabolic Strategy for Herpesvirus Replication. , 2018, Cell host & microbe.
[22] N. Popitsch,et al. Impaired plasticity of macrophages in X-linked adrenoleukodystrophy , 2018, Brain : a journal of neurology.
[23] N. Santos,et al. Effect of 25-hydroxycholesterol in viral membrane fusion: Insights on HIV inhibition. , 2018, Biochimica et biophysica acta. Biomembranes.
[24] T. Shenk,et al. Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype , 2017, Proceedings of the National Academy of Sciences.
[25] B. Gelman,et al. MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology , 2017, PLoS pathogens.
[26] S. Gygi,et al. A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells , 2017, Cell reports.
[27] S. Nichol,et al. 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation , 2016, mBio.
[28] E. Yang,et al. Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection , 2016, Journal of Virology.
[29] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[30] Daehyun Baek,et al. Temporal Landscape of MicroRNA-Mediated Host-Virus Crosstalk during Productive Human Cytomegalovirus Infection. , 2015, Cell host & microbe.
[31] F. Eichler,et al. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. , 2015, The application of clinical genetics.
[32] J. Rabinowitz,et al. Fatty Acid Elongase 7 Catalyzes the Lipidome Remodeling Essential for Human Cytomegalovirus Replication , 2015, Cell reports.
[33] Vineet D. Menachery,et al. Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates , 2014, BMC Genomics.
[34] F. Eichler,et al. Pathophysiology of X-linked adrenoleukodystrophy☆ , 2014, Biochimie.
[35] H. Stockinger,et al. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes , 2013, Human molecular genetics.
[36] H. Balfour,et al. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. , 2013, The Journal of infectious diseases.
[37] S. Itohara,et al. Impaired Epidermal Permeability Barrier in Mice Lacking Elovl1, the Gene Responsible for Very-Long-Chain Fatty Acid Production , 2013, Molecular and Cellular Biology.
[38] C. Wiesinger,et al. Impaired Very Long-chain Acyl-CoA β-Oxidation in Human X-linked Adrenoleukodystrophy Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction* , 2013, The Journal of Biological Chemistry.
[39] J. Rabinowitz,et al. Saturated Very Long Chain Fatty Acids Are Required for the Production of Infectious Human Cytomegalovirus Progeny , 2013, PLoS pathogens.
[40] T. Zhao,et al. [Expression pattern of hsa-miR-9 and its association with BCL6 in EBV-positive and EBV-negative Burkitt lymphoma cell lines]. , 2013, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[41] Lisa E. Gralinski,et al. Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus , 2013, mBio.
[42] Lisa E. Gralinski,et al. Release of Severe Acute Respiratory Syndrome Coronavirus Nuclear Import Block Enhances Host Transcription in Human Lung Cells , 2013, Journal of Virology.
[43] G. Cheng,et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. , 2013, Immunity.
[44] A. Kihara. Very long-chain fatty acids: elongation, physiology and related disorders. , 2012, Journal of biochemistry.
[45] D. Bartel,et al. Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs , 2011, Nature Structural &Molecular Biology.
[46] Yoav Gilad,et al. The effects of EBV transformation on gene expression levels and methylation profiles. , 2011, Human molecular genetics.
[47] Bryan R. Cullen,et al. Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus , 2010, Journal of Virology.
[48] Anjali J. Koppal,et al. Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .
[49] R. Wanders,et al. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy , 2010, EMBO molecular medicine.
[50] J. Hamilton,et al. Fast Diffusion of Very Long Chain Saturated Fatty Acids across a Bilayer Membrane and Their Rapid Extraction by Cyclodextrins , 2009, The Journal of Biological Chemistry.
[51] N. Blau,et al. Laboratory guide to the methods in biochemical genetics , 2008 .
[52] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[53] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[54] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[55] J. Mandel,et al. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. , 2004, Human molecular genetics.
[56] R. Schneiter,et al. Identification and biophysical characterization of a very-long-chain-fatty-acid-substituted phosphatidylinositol in yeast subcellular membranes. , 2004, The Biochemical journal.
[57] R. Küppers. B cells under influence: transformation of B cells by Epstein–Barr virus , 2003, Nature Reviews Immunology.
[58] R. Wanders,et al. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. , 2003, Molecular genetics and metabolism.
[59] J. Hamilton. Fast flip-flop of cholesterol and fatty acids in membranes: implications for membrane transport proteins. , 2003, Current opinion in lipidology.
[60] A. Holzinger,et al. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. , 1999, Human molecular genetics.
[61] H. Moser,et al. Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. , 1995, The Journal of clinical investigation.
[62] Y. Lange,et al. Cholesterol movement from plasma membrane to rough endoplasmic reticulum. Inhibition by progesterone. , 1994, The Journal of biological chemistry.